SZSE:002693 (China)
Â
Class A
Â¥
22.88
(-4.67%)
Nov 28
Business Description
Hainan Shuangcheng Pharmaceuticals Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100001K63
Share Class Description:
SZSE:002693: Class ACompare
Compare
Traded in other countries / regions
002693.China IPO Date
2012-08-08Description
Hainan Shuangcheng Pharmaceuticals Co Ltd is engaged in the research, development, and sales of synthesized peptide drugs.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.24 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.48 | |||||
| Debt-to-EBITDA | -2.13 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 14.6 | |||||
| Beneish M-Score | -3.12 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5.3 | |||||
| 3-Year EBITDA Growth Rate | 3.7 | |||||
| 3-Year EPS without NRI Growth Rate | 24.6 | |||||
| 3-Year FCF Growth Rate | 16.2 | |||||
| 3-Year Book Growth Rate | -2.4 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.94 | |||||
| 9-Day RSI | 42.54 | |||||
| 14-Day RSI | 46.75 | |||||
| 6-1 Month Momentum % | 619.62 | |||||
| 12-1 Month Momentum % | 393.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1 | |||||
| Quick Ratio | 0.49 | |||||
| Cash Ratio | 0.31 | |||||
| Days Inventory | 388.7 | |||||
| Days Sales Outstanding | 33.06 | |||||
| Days Payable | 83.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1 | |||||
| Shareholder Yield % | 0.17 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.23 | |||||
| Operating Margin % | -29.48 | |||||
| Net Margin % | -48.14 | |||||
| FCF Margin % | -20.03 | |||||
| ROE % | -18.51 | |||||
| ROA % | -10.59 | |||||
| ROIC % | -7.07 | |||||
| ROC (Joel Greenblatt) % | -21.82 | |||||
| ROCE % | -15.04 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 53.6 | |||||
| PB Ratio | 21.79 | |||||
| Price-to-Tangible-Book | 38.78 | |||||
| Price-to-Operating-Cash-Flow | 586.67 | |||||
| EV-to-EBIT | -103.14 | |||||
| EV-to-EBITDA | -103.14 | |||||
| EV-to-Revenue | 55.98 | |||||
| EV-to-FCF | -259.06 | |||||
| Price-to-Projected-FCF | 63.56 | |||||
| Price-to-Median-PS-Value | 5.87 | |||||
| Earnings Yield (Greenblatt) % | -0.97 | |||||
| FCF Yield % | -0.38 | |||||
| Forward Rate of Return (Yacktman) % | -6.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hainan Shuangcheng Pharmaceuticals Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 180.641 | ||
| EPS (TTM) (Â¥) | -0.207 | ||
| Beta | 3.86 | ||
| Volatility % | 246.27 | ||
| 14-Day RSI | 46.75 | ||
| 14-Day ATR (Â¥) | 2.703446 | ||
| 20-Day SMA (Â¥) | 27.2905 | ||
| 12-1 Month Momentum % | 393.02 | ||
| 52-Week Range (Â¥) | 3.67 - 40.98 | ||
| Shares Outstanding (Mil) | 414.69 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hainan Shuangcheng Pharmaceuticals Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hainan Shuangcheng Pharmaceuticals Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hainan Shuangcheng Pharmaceuticals Co Ltd Frequently Asked Questions
What is Hainan Shuangcheng Pharmaceuticals Co Ltd(SZSE:002693)'s stock price today?
The current price of SZSE:002693 is ¥22.88. The 52 week high of SZSE:002693 is ¥40.98 and 52 week low is ¥3.67.
When is next earnings date of Hainan Shuangcheng Pharmaceuticals Co Ltd(SZSE:002693)?
The next earnings date of Hainan Shuangcheng Pharmaceuticals Co Ltd(SZSE:002693) is .
Does Hainan Shuangcheng Pharmaceuticals Co Ltd(SZSE:002693) pay dividends? If so, how much?
Hainan Shuangcheng Pharmaceuticals Co Ltd(SZSE:002693) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers